QT
PRTK

Quantbot Technologies’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Quantbot Technologies’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,600
Closed -$12.3K – 2197
2022
Q4 		$12.3K Buy
6,600
+900
+16% +$2.24K ﹤0.01% 1491
2022
Q3 		$14K Hold
5,700
– – ﹤0.01% 1398
2022
Q2 		$11K Buy
5,700
+3,200
+128% +$6.98K ﹤0.01% 1523
2022
Q1 		$7K Buy
2,500
+1,300
+108% +$4.89K ﹤0.01% 1505
2021
Q4 		$5K Buy
1,200
+1,100
+1,100% +$5.22K ﹤0.01% 1385
2021
Q3 		$0 Sell
100
-4,093
-98% -$22.6K ﹤0.01% 2030
2021
Q2 		$28K Buy
+4,193
New +$33.9K ﹤0.01% 1176
2020
Q4 		– Sell
-10,274
Closed -$55K – 1782
2020
Q3 		$55K Buy
+10,274
New +$50.9K 0.01% 838
2018
Q1 		– Sell
-1,146
Closed -$20K – 1586
2017
Q4 		$20K Sell
1,146
-6,503
-85% -$136K ﹤0.01% 1071
2017
Q3 		$191K Buy
7,649
+491
+7% +$11.4K 0.02% 716
2017
Q2 		$172K Buy
+7,158
New +$158K 0.02% 699

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Quantbot Technologies's PRTK Position: Q1 2023 in Review

Quantbot Technologies sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2023, closing a stake of 6,600 shares — an estimated $12.3K sold.

Quantbot Technologies first reported a position in PRTK in Q2 2017 and held it in 11 quarters. The position peaked at $191K in Q3 2017. 63 funds tracked by Wall St. Rank hold PRTK as of Q1 2023.

  • Quantbot Technologies reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 6,600 Paratek Pharmaceuticals, Inc. shares in Q1 2023, an estimated $12.3K.
  • Quantbot Technologies first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2017 and held it in 11 quarters.
  • Quantbot Technologies's Paratek Pharmaceuticals, Inc. position peaked at $191K in Q3 2017.
  • 63 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.